Accessibility settings

This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (funded, already peer-reviewed, non-eHealth) (218) Wet Lab Protocols and Methods (8) Precision Medicine and Genetics (87) Prostate Cancer (55) Urology (49)

Published on in Vol 13 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/63551, first published .
Quantification of Urinary Exosomal Prostate-Specific Antigen for the Diagnosis of Prostate Cancer Using Clinical Laboratory–Based Techniques: Protocol for a Case-Control Study

Quantification of Urinary Exosomal Prostate-Specific Antigen for the Diagnosis of Prostate Cancer Using Clinical Laboratory–Based Techniques: Protocol for a Case-Control Study

Quantification of Urinary Exosomal Prostate-Specific Antigen for the Diagnosis of Prostate Cancer Using Clinical Laboratory–Based Techniques: Protocol for a Case-Control Study

Authors of this article:

Guorong Li1 Author Orcid Image ;   Yannick Tholance2 Author Orcid Image ;   Nora Mallouk3 Author Orcid Image ;   Louis Waeckel1, 4 Author Orcid Image ;   Pascale Flandrin5 Author Orcid Image ;   Bruno Bali1 Author Orcid Image ;   Lionel Badet1 Author Orcid Image ;   Pierre Cornillon6 Author Orcid Image
Article Authors Cited by (3) Tweetations Metrics

Journals

  1. Li F, Zhang X. Saliva-Based Polygenic Risk Scores and AI-Enhanced Imaging for Prostate Cancer Screening Beyond PSA. annals of urologic oncology 2025 View
  2. Belali R, Sameri M. Emerging strategies in exosome engineering: From cellular preconditioning to hybridization for targeted therapeutics. Biochemical and Biophysical Research Communications 2026;812:153533 View
  3. Jiao Z, Deng C, Hu J, Zhu S. Urine-based PSMA detection for noninvasive prostate cancer diagnosis: recent advances, translational challenges, and future perspectives. Frontiers in Oncology 2026;16 View